1. Home
  2. NPK vs ABUS Comparison

NPK vs ABUS Comparison

Compare NPK & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Presto Industries Inc.

NPK

National Presto Industries Inc.

N/A

Current Price

$145.12

Market Cap

983.1M

Sector

Industrials

ML Signal

N/A

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

N/A

Current Price

$4.71

Market Cap

884.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NPK
ABUS
Founded
1905
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
983.1M
884.7M
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
NPK
ABUS
Price
$145.12
$4.71
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
66.4K
2.2M
Earning Date
06-04-2026
01-01-0001
Dividend Yield
0.73%
N/A
EPS Growth
N/A
13.64
EPS
0.99
N/A
Revenue
$388,228,000.00
$6,171,000.00
Revenue This Year
N/A
$125.30
Revenue Next Year
N/A
N/A
P/E Ratio
$139.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$77.63
$2.71
52 Week High
$142.39
$5.10

Technical Indicators

Market Signals
Indicator
NPK
ABUS
Relative Strength Index (RSI) 70.20 58.40
Support Level $102.66 $4.18
Resistance Level N/A $5.01
Average True Range (ATR) 5.74 0.22
MACD 0.92 0.03
Stochastic Oscillator 78.34 80.79

Price Performance

Historical Comparison
NPK
ABUS

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: